-
Nucleocapsid and spike antibody responses following virologically confirmed SARS-CoV-2 infection: an observational analysis in the Virus Watch community cohort
(Hinzugefügt: 29.11.2022 um 16:29 Uhr)
https://www.sciencedirect.com/science/article/pii/S1201971222004490
-
Infection Control Measures and Prevalence of SARS-CoV-2 IgG among 4,554 University Hospital Employees, Munich, Germany
(Hinzugefügt: 17.02.2022 um 06:21 Uhr)
https://wwwnc.cdc.gov/eid/article/28/3/20-4436_article
-
Serologische Untersuchungen von Blutspenden auf Antikörper gegen SARS-CoV-2 (SeBluCo-Studie)
(Hinzugefügt: 17.12.2021 um 09:32 Uhr)
https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Projekte_RKI/SeBluCo_Zwischenbericht.html
-
Low Seroprevalence among Undetected COVID-19 Cases, Faroe Islands, November 2020
(Hinzugefügt: 19.11.2021 um 20:24 Uhr)
https://wwwnc.cdc.gov/eid/article/28/1/21-0917_article
-
Immunity to COVID-19 in India through vaccination and natural infection
(Hinzugefügt: 15.11.2021 um 07:23 Uhr)
https://www.medrxiv.org/content/10.1101/2021.11.08.21266055v1
-
Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Test Results With Persistent Physical Symptoms Among French Adults During the COVID-19 Pandemic
(Hinzugefügt: 09.11.2021 um 15:53 Uhr)
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2785832
-
SARS-CoV-2-Seroprävalenz im Pandemieverlauf in Deutschland
(Hinzugefügt: 05.11.2021 um 07:43 Uhr)
https://www.aerzteblatt.de/nachrichten/128803/SARS-CoV-2-Seropraevalenz-im-Pandemieverlauf-in-Deutschland
-
High anti-SARS-CoV-2 antibody seroconversion rates before the second wave in Manaus, Brazil, and the protective effect of social behaviour measures: results from the prospective DETECTCoV-19 cohort
(Hinzugefügt: 04.11.2021 um 08:38 Uhr)
https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(21)00355-7/fulltext
-
Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021
(Hinzugefügt: 15.09.2021 um 15:00 Uhr)
https://jamanetwork.com/journals/jama/fullarticle/2784013?guestAccessKey=b2cebb88-d0dc-43fa-bfee-daeff7dc6594&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=090221
-
Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study
(Hinzugefügt: 14.09.2021 um 07:43 Uhr)
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00479-5/fulltext
-
Israel startet Projekt mit Antikörpertests für Kinder
(Hinzugefügt: 07.08.2021 um 15:56 Uhr)
https://www.aerzteblatt.de/nachrichten/126210/Israel-startet-Projekt-mit-Antikoerpertests-fuer-Kinder
-
Coronavirus (COVID-19) latest insights: Antibodies
(Hinzugefügt: 06.08.2021 um 10:47 Uhr)
https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19latestinsights/antibodies
-
Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States
(Hinzugefügt: 09.07.2021 um 19:20 Uhr)
https://stm.sciencemag.org/content/13/601/eabh3826
-
COVID-19: Seroprävalenz erreicht in Stockholm vor Impfbeginn 20 %
(Hinzugefügt: 22.05.2021 um 17:02 Uhr)
https://www.aerzteblatt.de/nachrichten/124040/COVID-19-Seropraevalenz-erreicht-in-Stockholm-vor-Impfbeginn-20
-
Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Peru in July and August, 2020: a population-based study
(Hinzugefügt: 20.05.2021 um 06:17 Uhr)
https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(21)00173-X/fulltext
-
SARS-CoV-2 seroprevalence in Germany - a population based sequential study in five regions
(Hinzugefügt: 07.05.2021 um 06:34 Uhr)
https://www.medrxiv.org/content/10.1101/2021.05.04.21256597v1
-
SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study
(Hinzugefügt: 30.04.2021 um 05:41 Uhr)
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00072-2/fulltext
-
Coronavirus (COVID-19) Infection Survey, antibody and vaccination data for the UK: 28 April 2021
(Hinzugefügt: 29.04.2021 um 07:14 Uhr)
https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsurveyantibodydatafortheuk/28april2021
-
Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany
(Hinzugefügt: 19.04.2021 um 08:27 Uhr)
https://www.nature.com/articles/s41467-021-22351-5
-
Prevalence of SARS-CoV-2 IgG antibodies in a large prospective cohort study of elite football players in Germany (May–June 2020): implications for a testing protocol in asymptomatic individuals and estimation of the rate of undetected cases
(Hinzugefügt: 07.04.2021 um 07:54 Uhr)
https://www.sciencedirect.com/science/article/pii/S1198743X20307291
-
Covid-19 antibodies present in about 1 in 5 blood donations from unvaccinated people, according to data from the American Red Cross
(Hinzugefügt: 20.03.2021 um 18:35 Uhr)
https://edition.cnn.com/2021/03/15/health/red-cross-blood-donations-covid-antibodies/index.html
-
Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study
(Hinzugefügt: 19.03.2021 um 08:40 Uhr)
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00238-5/fulltext
-
Estimated SARS-CoV-2 Seroprevalence Among Persons Aged <18 Years — Mississippi, May–September 2020
(Hinzugefügt: 14.03.2021 um 21:46 Uhr)
https://www.cdc.gov/mmwr/volumes/70/wr/mm7009a4.htm?s_cid=mm7009a4_x
-
Prevalence of COVID-19 in adolescents and youth compared with older adults in states experiencing surges
(Hinzugefügt: 11.03.2021 um 09:00 Uhr)
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0242587
-
Risk Factors Associated With SARS-CoV-2 Seropositivity Among US Health Care Personnel
(Hinzugefügt: 11.03.2021 um 08:29 Uhr)
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2777317
-
Community COVID-19 Incidence and Health Care Personnel COVID-19 Seroprevalence
(Hinzugefügt: 11.03.2021 um 08:28 Uhr)
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2777310
-
SARS-CoV-2 Seroprevalence and Symptom Onset in Culturally Linked Orthodox Jewish Communities Across Multiple Regions in the United States
(Hinzugefügt: 11.03.2021 um 08:24 Uhr)
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2777318